Stock Report for Cell Therapeutics Inc. (CTIC)
  • Stock Report for Liquidmetal Technologies Inc. (LQMT)
  • Stock Report for FiberTower Corp. (FTWR)
  • " />

    Stock Report for Cybex International Inc. (CYBI)

    Cybex International Inc. (CYBI) is a manufacturer of premium exercise equipment primarily for commercial use. The Cybex product line, including a full range of strength and cardio training machines, is designed using exercise science to reflect the natural movement of the human body. Led by the Cybex Research Institute, Cybex fitness equipment is engineered to produce optimal results for users from the first-time exerciser to the professional athlete. Cybex products, designed and built in the USA, are available for a wide range of facilities, from commercial health clubs to home gyms, and are sold in more than 85 countries worldwide.

    Share Statistics (16-Feb-12)   FY












    Symbol  CYBI Revenue, $Mn 120.47 122.96 2.1% 29.23 33.48 14.5%
    Current price $2.35 Gross marg. 29.9% 36.5% 22.1% 35.9% 34.8% -3.1%
    52wk Range: $0.36-$2.02 Oper. margin -35.2% -0.1%
    Avg Vol (3m): 62,179 Net margin -2.0% -47.4% 2270.0% -0.0% -0.8%
    Market Cap. 39.38M              
    Shares Outstanding 17.12M EPS, $ -0.14 -1.46 942.9% 0.00 0.04

    Source:, SEC Filings.

    Investment Highlights

    Cybex International Inc. (CYBI) climbed as high as $2.80 Thursday, a fresh 52-week high, a day after it reported fourth-quarter results showing a swing to profit. The stock closed the session at $2.35, a 26% gain on the day, with above-average volume of 801 K shares traded.

    Shares in the international fitness equipment provider have risen 62.1% in the last five days; 452.9% in the last month; and 216.7% year-to-date.

    CYBI posted a net income of $34.7 million, or $2.03 per diluted share, for the fourth quarter ended December 31, 2011, reversing a net loss of ($57.1) million, or ($3.34) per diluted share, for the comparable quarter of the prior year. The 2011 and 2010 results include a 2010 litigation charge pertaining to the jury verdict in the product liability suit, Barnhard v. Cybex International Inc., and the 2011 adjustments to the charge relating to the settlement of the suit.

    Excluding these charges and adjustments, the Company earned $2.7 million, or $0.16 per fully diluted share, for the latest quarter period, and $1.5 million, or $0.09, per fully diluted share for 2010.

    CYBI reported net sales of $43.1 million for the quarter, compared to $39.9 million in the same period last year, an 8% increase.

    “Sales in North America increased 3% and sales outside North America increased 20% for the fourth quarter,” according to John Aglialor, chairman and CEO of CYBI.  “Importantly, we accomplished these results during a time of global economic uncertainty while confronting an unfair and excessive jury verdict which is now behind us. Our growth is a testament to the health of the company and the value customers have for our innovative and superior products.”

    CYBI shares spiked earlier this month after the Company announced that it has reached a settlement in the Barnhard product liability suit.  Pursuant to the settlement, CYBI will pay to the plaintiff, net of insurance, about $19.5 million of which approximately $18.5 million will be paid at the consummation of the settlement with the balance paid over seven years.

    As part of the settlement, the Company will be released of all further liability with respect to the litigation, which will be dismissed with prejudice. It will satisfy its cash obligation through available cash, its existing line of credit and additional financing, which it is in the process of arranging with its principal bank.


    Financial Strength (16-Feb-2012)




    S&P 500

    Quick Ratio (MRQ) 0.53 1.57 1.06 0.58
    Current Ratio (MRQ) 0.69 2.36 1.29 0.93
    LT Debt to Equity (MRQ) 12.97 56.14 171.55
    Total Debt to Equity (MRQ) 17.94 96.62 228.97
    Interest Coverage (TTM) 0.91 0.02 0.30 27.52

    Source:, SEC Filings.

    Technical Analysis


    CYBI is above the upper Bollinger Band, implying that it is currently extended from its recent trend. Be aware, however, that a cross outside of the Bollinger Bands can sometimes be a signal of trend strength and not, necessarily, trend reversal.

    The MACD for CYBI currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0, which implies that the underlying moving averages are trending higher.

    Comparative Analysis

    Company Name Ticker Price per Mrkt. Cap. P/E P/S
    Feb16-2011 symbol Share, $ $ Mn 2011 2012 2011 2012
    Brunswick Corp. BC 24.41 2.18B 17.31 12.92 0.56 0.52
    Nautilus Inc. NLS 2.74 84.55M n/a 18.27 0.48 0.44
    Sporting Goods Median       14.37 n/a 0.49 n/a
    Cybex International Inc. CYBI 2.35 39.89M n/a n/a 0.29 0.28

    Source: Thomson Financial

    DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority.  We are neither licensed nor qualified to provide investment advice.

    The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice.  The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities.  We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

    Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.  An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report.  Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

    Any individual who chooses to invest in any securities should do so with caution.  Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested.  Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

    Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934.  Subscribers are cautioned not to place undue reliance upon these forward looking statements.  These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated.  Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC.  You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

    We are committed to providing factual information on the companies that are profiled.  However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions.  We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so.  Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.

    To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).

    We encourage you to invest carefully and read investment information available at the websites of the SEC at and FINRA at

    Leave a Reply

    Your email address will not be published. Required fields are marked *